News Related to LCN2 Antibody

Related coverage linked through entity extraction aliases.

Three New Strategies Target Cancer Through Protein Regulation and Immune System Activation

Feb 25, 2026

Researchers report advances in cancer treatment through three distinct approaches: repurposing a heart medication to target lymphoma enzymes, blocking stress proteins to enhance immunotherapy, and developing antibodies that restore immune system attacks on tumors.

Stress Protein LCN2 Helps Lung and Pancreatic Tumors Evade Immune Attack

Feb 19, 2026

Researchers discovered that lipocalin 2 (LCN2), a protein released by stressed cancer cells, helps lung and pancreatic tumors evade the immune system by manipulating macrophages and blocking T cell infiltration.